Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 10, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 13, 2025
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001533302-25-000007
Filed / recorded
Dec 13, 2025, 12:05 AM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Samir M. Gharib
Relationship
Officer
Officer title
PRESIDENT AND CFO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Dec 10, 2025
Transaction code
M
Shares / units
514
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
6,580
Ownership form
Direct
Amendment
No
Footnotes from the filing
On March 14, 2024, the Reporting Person was granted a total of 2,053 RSU's. Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective. 25% of the total number of the RSUs will vest on each of the second, third and fourth anniversaries of such achievement. On December 10, 2025, 514 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 330 shares.
Each RSU represents a contingent right to receive one share of SPRB common stock.